Announced Wed, 15 Jul · 17:16 IST
ITAT quashes tax order, sends case back for fresh hearing
Regulatory & Legal View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.3%1-day move
₹8.00
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-1.3-2.4-2.9-3.9-2.6-3.9————
Up moveDown movePending
AI summary
Indrayani Biotech told BSE that the Income Tax Appellate Tribunal (ITAT) has quashed an order from the First Appellate Authority in an income tax case and sent it back for fresh adjudication. The dispute relates to an Assessment Order dated March 26, 2025, which the company had challenged. ITAT issued its order on July 14, 2026. Status of the litigation has moved from Ongoing to Culminated, though a fresh hearing now lies ahead.
Likely market impact
Neutral to mildly positive for shareholders. The unfavorable appellate order was set aside, giving the company another chance, but the tax dispute is still unresolved.